Daniel Barber

Daniel Barber

President and Chief Executive OfficeratAquestive Therapeutics· In proxies 2022–2025

Pay in FY2025-16% from the year before · Aquestive Therapeutics stock +81.5% the same year

Daniel Barber was paid $3.5M in FY2025 (Dec), down 16%. Aquestive Therapeutics stock rose 81.5% that year.

Pay$100 in the stock at the end of FY21 → $166
Pay is from the Summary Compensation Table of each Aquestive Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Aquestive TherapeuticsPublic company · 4 yr
    • President and Chief Executive Officer2022 – Present · 4 yrStock in role +7%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?